• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Unocal

Unocal

Fidelity Advisor Asset Manager® 20% A FTAWX 2 Star

Last Price$13.01Day Change (%)0.31%
Open Price$13.01Day Change ($)0.04
Day Range13.01–13.0152-Week Range12.37–13.30

As of Wed 06/29/2016 | USD

  1. All
  2. 3rd Party
  3. Investing
  1. LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer

    LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer

  2. Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System

    Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System

  3. The Year in Stocks: The Rally Continues

    Mid-caps and energy lead the way; growth shows signs of life.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.